Mineralys Therapeutics, Inc. (MLYS) Tops Q1 EPS by 29c

Mineralys Therapeutics, Inc. (NASDAQ: MLYS) reported Q1 EPS of ($0.79), $0.29 better than the analyst estimate of ($1.08).

For earnings history and earnings-related data on Mineralys Therapeutics, Inc. (MLYS) click here.

You May Also Be Interested In

• X Financial (XYF) Tops Q2 EPS by 438c
• Strategy sets up $1.59 billion cash pool to buy Bitcoin
• Bitmine reports 5.85M ETH holdings, total assets at $14.9B